A male patient underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation (procep) became aware that post-discharge the patient went into the emergency room and was taken back into the operating room two (2) times due to bleeding, clot retention, and being unable to void (per manufacturer's instructions for use, bleeding, urethral damage causing false passage, and urinary retention are perioperative risks of the aquablation procedure).The patient had undergone multiple catheterizations causing multiple false urethral passages.The treating surgeon performed clot evacuation to clear the clots and the patient was catheterized for an additional month to allow for healing of the area, including the false urethral passages.No malfunction of the aquabeam robotic system was reported.
|
The aquabeam robotic system is a reusable device; therefore, it is still currently in possession of the user facility.The device was not returned for investigation because it performed as intended during the aquablation procedure.The investigation consisted of a review of the information reported to procept, plus a review of the treatment log files, device history record (dhr),and labeling.The treatment log files were not made available for review.The aquabeam robotic system's treatment logs file was reviewed, which confirmed no malfunctions during the aquablation procedure.The review of the treatment logs indicated that the system functioned as designed.A review of the device history record (dhr) ab2000-b rev d / serial number 22c00143 was conducted, which confirmed that there were no non-conformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the system met all design and manufacturing specifications when released for distribution.The aquabeam robotic system instructions for use (ifu), ifu0101-00, rev.E, was reviewed and states the following: 4.3.Warnings: procedure as with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include: bleeding; urethral damage causing false passage or stricture; urinary retention.The device was not returned for investigation because it performed as intended during the aquablation procedure.The aquabeam robotic system instructions for use list bleeding, urethral damage causing false passage, and urinary retention as potential risks of the aquablation procedure.Based on the review of the treatment log files, dhr, and ifu, the event is considered not to be device-related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|